Clinical Trials Browser

Phase 2 × Interferon alpha-2 × Plasma cell × Clear all

NCT00006244 2017-07-12

Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma

Phase 2 Completed

36 enrolled 14 charts

Multiple Myeloma

NCT00323505 2006-05-09

A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma

Phase 2 Completed

Multiple Myeloma